TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

DISCO Pharmaceuticals Appoints Mark Manfredi as CEO and Announces Final Close of €36 Million Seed Financing

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Mark Manfredi
DISCO Pharmaceuticals Appoints Mark Manfredi as CEO and Announces Final Close of €36 Million Seed Financing

DISCO Pharmaceuticals appointed Mark Manfredi as CEO and closed a €36 million seed financing round to advance its surfaceome-targeted drug candidates for cancer treatment, with support from multiple venture capital investors.

Insights
AVHNY   positive

Co-led seed financing round, expressed confidence in DISCO's technological platform